Machine Learning AI Therapeutics Announces Name Change to OrphAI Therapeutics PRNewswire Oct 1, 2023 AI Therapeutics, a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced that it has changed its name to…
Machine Learning Tempus Announces Companion Diagnostic Collaboration with TScan Therapeutics Business Wire Jul 10, 2023 Tempus, a leader in artificial intelligence and precision medicine announced a new collaboration to develop a companion diagnostic (CDx) test with…
Natural Language Sumitovant Biopharma Helps Identify More Than 80 Peptide Drug Candidates for Neochromosome’s… AIT News Desk Jan 20, 2023 Sumitovant Biopharma, a technology-driven biopharmaceutical company accelerating the development and commercialization of novel therapeutics,…
Machine Learning Lantern Pharma Receives Pre-IND Feedback from the FDA, Clearing a Path for Drug Candidate LP-184’s… AIT News Desk Jan 17, 2023 Lantern Pharma , a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") and machine learning (“M.L.”)…
Machine Learning METiS Announces License Agreement with Evopoint Biosciences AIT News Desk Jan 7, 2023 METiS Therapeutics (METiS), a Boston-area company integrating drug discovery and delivery with AI and machine learning,announced they have entered a…
Healthcare Management Lantern Pharma Expands Precision Oncology Collaboration With The National Cancer Institute… AIT News Desk Jan 12, 2022 Lantern Pharma a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") platform to transform the cost,…
Healthcare Management Palatin Announces Initiation Of Pivotal Phase 3 PL9643 MELODY-1 Clinical Trial In Patients With Dry… AIT News Desk Dec 28, 2021 Top-Line Results Currently Expected Second Half Calendar 2022 Palatin Technologies, Inc. a specialized biopharmaceutical company developing…
Machine Learning Gilead And AWS Collaborate On Development And Delivery Of New Medicines For Patients AIT News Desk Nov 30, 2021 With AWS as its preferred cloud provider, Gilead uses AWS machine learning and analytics to better inform clinical trial design and advance…
Healthcare Management Everest Medicines Announces Up To HK$100 Million Additional Share Repurchase Program AIT News Desk Nov 8, 2021 Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative…
Healthcare Management Viking Therapeutics To Present Preclinical Data On Novel Dual GLP-1/GIP Agonists At ObesityWeek 2021 AIT News Desk Oct 25, 2021 Poster Presentations to Highlight Data From the Company's Multi-Receptor Agonists in a Rodent Model of Obesity Viking Therapeutics, Inc. a…